Pentixapharm Holding AG (ETR:PTP)
Germany · Delayed Price · Currency is EUR 2.500
+0.100 (4.17%)
At close: May 29, 2026
Pentixapharm Holding AG Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Jan '25 Jan 1, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 0.07 | 0.09 | 0.78 | 4.77 | 3.97 | 2.6 |
Other Revenue | 0.32 | 0.43 | 1.27 | 1.74 | - | 0 |
| 0.4 | 0.53 | 2.05 | 6.51 | 3.97 | 2.6 | |
Revenue Growth (YoY) | -58.47% | -74.37% | -68.49% | 64.04% | 52.67% | - |
Cost of Revenue | 6.22 | 6.92 | 3.78 | 0.05 | - | - |
Gross Profit | -5.82 | -6.39 | -1.73 | 6.46 | 3.97 | 2.6 |
Selling, General & Admin | 6.73 | 6.89 | 2.26 | 2.29 | 1.26 | 1.13 |
Other Operating Expenses | 2.5 | 2.85 | 3.34 | 10.11 | 4.77 | 3.01 |
Operating Expenses | 12.94 | 13.47 | 24.68 | 12.55 | 6.14 | 4.24 |
Operating Income | -18.76 | -19.86 | -26.41 | -6.09 | -2.17 | -1.64 |
Interest Expense | -0.03 | - | -0.1 | -0.18 | - | -0 |
Interest & Investment Income | 0.25 | 0.35 | 0.57 | 0.13 | - | - |
Earnings From Equity Investments | - | - | - | - | 1.4 | -0.09 |
Currency Exchange Gain (Loss) | - | - | 0.01 | -0.07 | -0 | -0 |
EBT Excluding Unusual Items | -18.58 | -19.51 | -25.92 | -6.21 | -0.78 | -1.73 |
Gain (Loss) on Sale of Assets | - | - | 6.7 | - | - | - |
Other Unusual Items | - | - | 1.72 | - | - | - |
Pretax Income | -18.58 | -19.51 | -17.5 | -6.21 | -0.78 | -1.73 |
Income Tax Expense | -2.9 | -3 | -4.44 | 1.43 | 1.18 | 0.76 |
Net Income | -15.68 | -16.51 | -13.06 | -7.64 | -1.96 | -2.49 |
Net Income to Common | -15.68 | -16.51 | -13.06 | -7.64 | -1.96 | -2.49 |
Shares Outstanding (Basic) | 25 | 25 | 25 | 22 | - | - |
Shares Outstanding (Diluted) | 25 | 25 | 25 | 22 | - | - |
Shares Change (YoY) | - | - | 14.21% | - | - | - |
EPS (Basic) | -0.63 | -0.67 | -0.53 | -0.35 | - | - |
EPS (Diluted) | -0.64 | -0.67 | -0.53 | -0.35 | - | - |
Free Cash Flow | -15.22 | -18.6 | -7.35 | -2.81 | -6.24 | -4.1 |
Free Cash Flow Per Share | -0.61 | -0.75 | -0.30 | -0.13 | - | - |
Gross Margin | - | - | -84.26% | 99.17% | 100.00% | 100.00% |
Operating Margin | -4724.69% | -3775.66% | -1286.53% | -93.49% | -54.70% | -63.09% |
Profit Margin | -3949.62% | -3138.97% | -636.25% | -117.27% | -49.38% | -95.81% |
Free Cash Flow Margin | -3834.51% | -3535.74% | -358.22% | -43.18% | -157.24% | -157.75% |
EBITDA | -18.52 | -19.6 | -26.34 | -5.94 | -2.06 | -1.54 |
EBITDA Margin | - | - | - | -91.23% | -51.83% | -59.02% |
D&A For EBITDA | 0.24 | 0.26 | 0.07 | 0.15 | 0.11 | 0.11 |
EBIT | -18.76 | -19.86 | -26.41 | -6.09 | -2.17 | -1.64 |
EBIT Margin | - | - | - | -93.49% | -54.70% | -63.09% |